About | Free Trial

Last Update

2015-12-05T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Peter Glick?

Mr. Peter Glick H.

Chairman

Blue Sky BioServices

HQ Phone: (800) 383-7795

Blue Sky BioServices

50 Prescott Street

Worcester, Massachusetts 01605

United States

Company Description

Blue Sky offers our clients top-of-the-range molecular biology services including: Chain Blue Lightning gene synthesis Subcloning and plasmid construction Vector construction and modification Construct generation Site-directed mutagenesis Genetic (cDNA)... more

Find other employees at this company (36)

Background Information

Employment History

General Partner

Ampersand Ventures

President

Primedica Corporation

Executive Chairman

Dynex Technologies , Inc.

Chairman

Magellan Biosciences Inc

Education

B.S.
Ecomomics
Wharton

BS
Economics
The Wharton School at the University of Pennsylvania

Bachelor's degree
Economics
Wharton School at the University of Pennsylvania

M.S.
Management
MIT

M.S.
Management
Sloan School at MIT

MS
Management
MIT's Sloan School

Master's degree
Management
Sloan School at the Massachusetts Institute of Technology

Master's degree
Management
Sloan School of Management at Massachusetts Institute of Technology

master's degree
management
The Sloan School of Management at Massachusetts Institute of Technology

Web References (87 Total References)


Magellan Diagnostics

www.magellandx.com [cached]

Peter Glick, Chairman of the Board

Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, and Blue Sky Bioservices. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.


Magellan Diagnostics

www.magellanbio.com [cached]

Peter Glick, Chairman of the Board

Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, and Blue Sky Bioservices. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.


Magellan Diagnostics

magellandx.com [cached]

Peter Glick, Chairman of the Board

Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, Blue Sky Bioservices, and Ekam Imaging. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.


Blue Sky BioServices - Board of Directors

www.blueskybiotech.com [cached]

Peter Glick Chairman of the Board


About us – Magellan Diagnostics (formerly ESA, Inc.) - LeadCare® II

www.leadcare2.com [cached]

Peter Glick, Chairman of the Board

Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, and Blue Sky Bioservices. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.

Similar Profiles

Other People with this Name

Other people with the name Glick

Martin Glick
The Business Solution Group

Priscilla Glick
Destination Nashville

Nancy Glick

Shay Glick
Fischer Behar Chen & Co

John Glick
CRAFT BREW ALLIANCE, INC.

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory